Wellgistics Health, Inc. (NASDAQ:WGRX – Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 6,271,116 shares, a growth of 219.6% from the February 26th total of 1,962,253 shares. Based on an average daily volume of 7,921,583 shares, the days-to-cover ratio is currently 0.8 days. Approximately 12.6% of the company’s shares are sold short.
Institutional Investors Weigh In On Wellgistics Health
A number of institutional investors have recently made changes to their positions in WGRX. Raymond James Financial Inc. raised its stake in shares of Wellgistics Health by 593.8% in the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock valued at $52,000 after acquiring an additional 50,000 shares during the period. XTX Topco Ltd boosted its position in shares of Wellgistics Health by 195.1% during the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock worth $42,000 after purchasing an additional 70,137 shares during the period. ORG Wealth Partners LLC purchased a new position in shares of Wellgistics Health during the 3rd quarter worth approximately $89,000. Geode Capital Management LLC increased its holdings in Wellgistics Health by 81.0% in the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock valued at $195,000 after purchasing an additional 218,170 shares during the last quarter. Finally, Heights Capital Management Inc. acquired a new stake in Wellgistics Health in the 3rd quarter valued at approximately $2,588,000.
Wellgistics Health Stock Performance
Shares of Wellgistics Health stock opened at $0.11 on Friday. The firm has a market cap of $11.66 million and a PE ratio of -0.08. The company has a quick ratio of 0.16, a current ratio of 0.09 and a debt-to-equity ratio of 1.86. Wellgistics Health has a 52 week low of $0.11 and a 52 week high of $7.04. The business’s fifty day simple moving average is $0.26 and its 200-day simple moving average is $0.54.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Wellgistics Health in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.
Check Out Our Latest Analysis on WGRX
About Wellgistics Health
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Featured Articles
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
